Skip to content
thestock.space

As of 6 Nov 2026, Medplus Health Services trades at 34.3× trailing earnings, above the industry P/E of 27.6×, and the shares are 41% below their 52-week high. It earns ROCE of 12% and ROE of 11%, and sales and net profit grew 15% and 64% a year over 3 years. Debt is 0.75× equity. It is a small-cap company with a market cap of ₹7,260 Cr, the largest of 8 Pharmaceutical Retailers companies by market cap; the shares fell 26% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹604.00
Day high
₹616.75
Day low
₹595.80
Prev. close
₹600.65
Volume
3.1 L

Health check

2 fair · 4 to check
  • ReturnsBehind

    −25.7% over a year, better than 2 of 7 peers.

  • Price tagPricier

    P/E 34.3 vs industry 27.6.

  • GrowthSteady

    Sales +14.7%, profit +64.0% a year over 3 years.

  • ProfitabilityAverage

    ROCE 12.2% vs peer median 5.2%.

  • Balance sheetStretched

    Debt 0.75× equity, interest covered 3.3×, Piotroski 3 of 9.

  • Red flags1 to check

    41% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Pharmaceutical Retailers

7 listed peers. Screen the industry

Small cap

₹7,260 Cr, the largest of 8 in its industry.

Defensive

Beta 0.50 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹7,587 Cr · profit ₹211 Cr
Market cap
₹7,260 Cr
Small cap
P/E
34.3
Industry 27.6
Price to book
3.47
Peers 2.61
Dividend yield
0.00%
ROE
10.8%
Peers 8.7%
ROCE
12.2%
Peers 5.2%
Debt to equity
0.75
Debt ₹1,549 Cr
EPS (TTM)
₹17.62
Face value ₹2
OPM (TTM)
8.3%
Net margin 2.8%
Sales growth
+21.3%
Latest quarter vs a year ago
Profit growth
+2.2%
Latest quarter vs a year ago
Price to sales
0.96
EV/EBITDA 19.5

Strengths and risks

Strengths

  • Quarterly sales up 21.3% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • 41% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Medplus Health Services

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness items, such as prescription medicines, over-the-counter drugs, vitamins, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also…

Headquarters
Hyderabad
Employees
28,872
Sector
Healthcare
ISIN
INE804L01022
Website
medplusindia.com

Price range

52 weeks

₹565.60₹1,022.20

Today

₹595.80₹616.75
Avg volume (3M)
1.4 L
1-year return
minus 25.7%
From 52-week high
minus 40.9%

Analyst consensus

7 analysts
Strong buyMean target ₹885.43 plus 46.4%

Target range, with today’s price

Low ₹670.00High ₹1,148.00

Today’s price ₹604.60 is below the lowest analyst target.

Consensus from Yahoo Finance. Not a recommendation.

Peers · Pharmaceutical Retailers

Compare with peersScreen the whole industry
Company
MEDPLUSMedplus Health Services604.60plus 0.66%7,26034.33.4712.2%10.8%4.2%14.7%64.0%0.00%minus 25.7%
HEALTHXHealth X Platform272.55minus 0.42%867–1.35−0.2%0.2%−4.4%8.0%–0.00%minus 8.3%
ONEGLOBALOne Global Service Provider365.45minus 7.66%7149.75.0665.7%65.3%19.2%201.8%269.3%0.23%minus 32.0%
TLLTrident Lifeline413.75minus 2.07%49521.04.2221.8%23.6%22.8%59.7%46.8%0.24%plus 40.8%
ACHYUTAchyut Healthcare7.76plus 4.86%187776.05.451.1%1.0%2.2%62.6%10.9%0.00%plus 28.7%
MAITRIMaitri Enterprises31.20plus 0.32%1437.62.6119.9%12.1%5.4%35.8%–0.00%minus 11.4%
MULLERMuller & Phipps (India)193.80plus 3.11%12–−5.821.8%–−17.2%12.9%–0.00%minus 23.9%
DPLDipna Pharmachem4.31plus 1.65%1110.50.185.2%5.2%21.2%7.7%2.2%0.00%minus 78.4%
Median of 7 peers–0.32%18721.02.615.2%8.7%5.4%35.8%28.9%0.00%−11.4%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Dec 25Mar 26Jun 26Sep 26
1,5431,8061,8641,8802,037
1,4121,6481,6951,7461,867
131159169133170
8.5%8.8%9.1%7.1%8.3%
1518.220.619.820.5
27.430.833.533.336.6
65.672.775.977.983.8
52.873.380.341.970.1
19.8%21.1%20.4%20.8%20.1%
42.457.86433.256.1
3.534.815.332.764.72

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+14.7%
Profit CAGR 3Y
+64.0%
EPS CAGR 3Y
+63.7%
ROE
10.8%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4,5295,5746,0876,835
–+23.1%+9.2%+12.3%
4,2595,2185,5836,210
269356505626
5.9%6.4%8.3%9.2%
39.134.424.449.3
8396.4103120
182224250283
3.73.96.63.9
47.273.4183275
−6.2%10.7%18.0%20.2%
49.865.5150220
–+31.6%+129.6%+46.1%
4.175.4512.5218.29

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
23.923.923.924
1,4671,5541,7171,951
9001,0101,1201,424
406417500533
2,7973,0053,3603,933
1,1181,2031,2621,578
27.46.813.833.2
0.15.12.41.7
289165440592
1,3631,6251,6421,727
2,7973,0053,3603,933

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
90.4144540496
429−82.8−318−128
−170−198−228−256
350−137−5.2112
−169−84.4−59.5−123
−78.659.3481373

Shareholding pattern

Source: NSE filings
40.2%
promoters
  • Promoters40.19%
  • Public59.76%
  • Employee trusts0.04%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202640.19%59.76%0.00
30 Jun 202640.19%59.77%minus 0.03
31 Mar 202640.22%59.74%minus 0.07
31 Dec 202540.29%59.66%0.00
30 Sep 202540.29%59.66%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you